Navigation Links
CSL Behring Parent Company, CSL Limited, Issues Fourth Corporate Responsibility Report
Date:12/3/2012

water consumption and greenhouse gas emissions per unit of plasma production.

"CSL's reputation as one of the most innovative biopharmaceutical companies in the world and our continued growth are underscored by our commitment to conducting our business responsibly, and actively contributing to the well-being of our communities," said Dr. Brian McNamee, CEO and Managing Director of CSL Limited. "Our Corporate Responsibility Report for 2012 demonstrates this ongoing commitment."

About CSL Limited
Headquartered in Melbourne, Australia, CSL Limited (AUX: CSL) is a global biopharmaceutical company that develops, manufactures and markets biotherapies to prevent and treat rare and serious human diseases. CSL owns major facilities in Australia, Germany, Switzerland and the US, and employs over 11,000 people in more than 25 countries. For more information visit www.csl.com.au.

About CSL Behring
CSL Behring is a leader in the plasma protein therapeutics industry. Committed to saving lives and improving the quality of life for people with rare and serious diseases, the company manufactures and markets a range of plasma-derived and recombinant therapies worldwide.

CSL Behring therapies are used around the world to treat coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic diseases in the newborn. For more information visit http://www.cslbehring.com/. CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma.

View Our Corporate Responsibility 2012 at http://corporateresponsibility.csl.com.au/.

Contact:
Chris Florentz 
M
'/>"/>

SOURCE CSL Behring
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema
2. CSL Behring Announces FDA Filing of Biologics License Application for 4-Factor PCC for Urgent Reversal of Vitamin K Antagonist Anticoagulant Therapy
3. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
4. Parent Project Muscular Dystrophy Endorses Senate Version of Prescription Drug User Fee Act After Patient Voice Strengthened
5. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
6. Parents Less Likely To Develop Colds, Carnegie Mellon Research Shows
7. National Call-to-Action to Boost Meningitis Vaccination Rates Supported by Leading Health Organizations, Urges St. Louis Parents to Vaccinate Preteens and Teens
8. National Call-to-Action to Boost Meningitis Vaccination Rates Supported by Leading Health Organizations, Urges Nashville Parents to Vaccinate Preteens and Teens
9. National Call-to-Action to Boost Meningitis Vaccination Rates Supported by Leading Health Organizations, Urges Minneapolis-St. Paul Parents to Vaccinate Preteens and Teens
10. TUV Rheinland Confirms Apparent Fraud in Mislabeling of DRX Products Manufactured by HTRD and Excite Medical
11. Webcams Help Parents Keep Watch Over Their Babies During Hurricane Isaac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... LA JOLLA, Calif. , Nov. 26, 2014 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery and development ... Kleanthis G. Xanthopoulos , Ph.D., President and CEO of ... th Annual Piper Jaffray Healthcare Conference at the ... at 2:00 p.m. EST.  The presentation will be webcast ...
(Date:11/26/2014)... Scott Steiger lives in St. Louis ... for the past 20 years, he,s traveled extensively and prior to ... to six of the seven continents. Travel is a big part ... Photo - http://photos.prnewswire.com/prnh/20141126/161077 So when he ... idea of what,s required. His latest creation is the ...
(Date:11/26/2014)... -- CARsgen, a leader in the development of Chimeric Antigen ... of cancers, today announced the completion of a series ... -based healthcare private equity fund.   ... of new therapeutics for liver, lung, stomach and brain ... Renji Hospital, the company plans to initiate clinical studies ...
Breaking Medicine Technology:Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3Steiger Has Created the First Pill Case Specifically Designed For Travel 2CARsgen Completes Series A Financing 2
... , , SAN DIEGO, Nov. ... to present at the 21st Annual Piper Jaffray Health Care Conference ... 1, 2009 at 1:00 p.m. Eastern Time. , (Logo: ... be accessible on the Investors page of the Company,s website at ...
... MATEO, Calif., Nov. 24 NeurogesX, Inc. (Nasdaq: NGSX ... pain management therapies, today announced the appointment of John A. ... Mr. Orwin is a 20-year sales and marketing veteran in ... of several important therapeutics. , Mr. Orwin currently serves as ...
Cached Medicine Technology:Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 2NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 3NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director 4
(Date:11/27/2014)... Two international trainers and lecturers on the ... one person with significant needs but limited means obtain ... Mamaly Reshad of the Anacapa Dental Art Institute in ... devoted to helping dentist learn about using All-on-4™ dental ... devoted to helping a patient who has damaged or ...
(Date:11/27/2014)... “LAB.C” was featured on NewsWatch as part ... coolest technology products available to consumers. Mallory Sofastaii, a technology ... and shared with viewers the company offers a cable ... , Consumers love portability and functionality. A unique mobile ... the iPhone5 and 5S has a portable USB charger built ...
(Date:11/27/2014)... Texas (PRWEB) November 27, 2014 ... report on Global Insulin industry. For an overview ... definition, classification, application, industry chain structure, industry overview, ... on global Insulin industry covers information on ... process, product cost structure and much more. ...
(Date:11/27/2014)... 27, 2014 Allowing children to help with ... school, helps give children responsibility, ownership, boosts self-esteem, and above ... , Now, the real question is, how do you encourage ... According to a study published by Child Development Journal, there ... dramatic effect on a child’s willingness to lend a hand. ...
(Date:11/27/2014)... 27, 2014 RBSEO Services, a ... engine optimization service just at $99. RBSEO Services ... cannot afford costly search engine optimization service. So, ... their affordablity and requirements into consideration. , ... it has not compromised with the service quality. ...
Breaking Medicine News(10 mins):Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 3Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 4Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 5Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3Health News:RBSEO Services Announces SEO Services at $99 Only 2
... McClellan to Give Keynote Speech, WASHINGTON, June ... molecular machinery is pointing toward new drugs and,treatments ... emerging,era of health care, called personalized medicine, also ... and industry,marketing strategies., To help the food ...
... New West,s Ability to Provide Outstanding ... Healthcare Service and Access, ... PER ) and New West Health Services -- Montana,s second,largest ... Systems will host New West,s enterprise core administrative,system (CAS), and ...
... (St. Mary,s City, MD) June 12, 2008Encore Creativity for ... will co-host Encore,s first Summer Chorale Camp Tuesday, June ... executive director Jeanne Kelly helped lead a study about ... between regular artistic activity and improved physical and mental ...
... Ovarian function can be preserved and disease activity controlled ... treated with a 6-month course of cyclophosphamide (CYC), a ... according to a new study presented today at EULAR ... Rheumatism in Paris, France. , SLE, a complex ...
... Standards and Technology (NIST) have developed a simplified, ... for biological research. By using a laboratory microwave ... used nanomaterials, the recently published* NIST process avoids ... making quantum dots, resulting in brighter, more stable ...
... a stroke, even unaffected areas of the brain are at ... dead tissue and spread through the adjacent areas of the ... has previously been observed only in animal studies. , A ... along with the Max Planck Institute of Neurological Research in ...
Cached Medicine News:Health News:FDLI, AAAS Host June 20 Conference on Personalized Medicine 2Health News:FDLI, AAAS Host June 20 Conference on Personalized Medicine 3Health News:New West Health Services Selects Perot Systems Xcelys(TM) 5.0 Software 2Health News:New West Health Services Selects Perot Systems Xcelys(TM) 5.0 Software 3Health News:NIH study concludes next week's summer chorus camp for seniors improves quality of life 2Health News:Ovarian function and fertility preserved in women with severe systemic lupus erythematosus 2Health News:Microwave synthesis connects with the (quantum) dots 2Health News:Tsunami in the brain 2Health News:Tsunami in the brain 3
The CA-500 series quickly and accurately measures up to 5 coagulation parameters. It is the analyzer of choice for low to mid volume laboratories, or as a backup to larger coagulation analyzers....
... is our top-of-the-line device. The ... of the Qwik-Let® Elite, in ... feature. The Lan-X technology allows ... in the removal and disposal ...
... The new Finnpipette Focus from Thermo ... with uncompromising performance. Advanced features such ... .01ul fine volume adjustment on microvolumes help ... in single channel pipettes. The new interchangeable ...
... Digital offers improved ergonomics for today's ... modified grippy finger rest and the ... and efficiency. Finnpipette Digitals also feature ... mechanism (pat. pend.) and super blow-out ...
Medicine Products: